← Back to all trials
Completed
NCT05680441
GCF Annexin-A1, Carbonic Anhydrase-1, and Elongation Factor-1 Gamma Levels in Periodontitis
Conditions: Periodontitis, Periodontal Inflammation
Sex: All
Ages: 20 Years – 61 Years
Healthy volunteers: 1
Enrollment: 80
Sponsor: Dokuz Eylul University
Location: Turkey
Summary
The study aimed to investigate gingival crevicular fluid (GCF) levels of possible novel biomarkers Annexin-A1 (ANX A1), Carbonic anhydrase- 1 (CA I), and Elongation Factor-1 Gamma (EF1-Ɣ) in health along with different periodontal diseases.In total, 80 systemically healthy individuals were included in this study; 20 with periodontitis stage 3 grade B , 20 with periodontitis stage 3 grade C (P-Stage III/C), 19 with gingivitis, and 21 with clinically healthy periodontium.
Probing depth, clinical attachment level, plaque index, and papillary bleeding index were recorded.
GCF ANX A1, CA I and EF1-Ɣ levels were analyzed by enzyme-linked immunosorbent assay (ELISA).
Receiver operating characteristics curve was used for estimating the under the curve.
Eligibility Criteria
Inclusion Criteria:Non-smokers with no history of smoking(determined by self-reporting)Individuals who had at least 20 teeth(exclude wisdom teeth)Exclusion Criteria:Pregnant and lacting womenPatients who under any medication including immunosuppressants, steroids, non-steroidal anti-inflammatory drugs, antibiotics, antiepileptic drugs, calcium channel blockers, beta,blockers, anticoagulants, hormonal contraceptives and nutritional supplements within 6 monthsi topical antiseptic solutions in the last 3 months.Patients with diagnosed medical illness such as diabetes mellitus, rheumatoid arthritis, cardiovascular diseases, immunological diseases.
Source: ClinicalTrials.gov (NCT05680441). StuddyBuddy aggregates publicly available trial information.